Prostate cancer decisions — 2022
1,116 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: DeniedNovember 2022
The Veteran's claim for service connection for obstructive sleep apnea was denied as it was not proximately due to or aggravated by the service-connected PTSD, coronary artery disease, and diabetes mellitus. The Veteran's prostate cancer was rated at 20% from October 1, 2012 through December 31, 2013, with a TDIU granted based on his service-connected PTSD.
- Whole decision: GrantedNovember 2022
The Veteran's service-connected disabilities prevent him from securing or following a substantially gainful occupation since July 1, 2020.,The Veteran submitted VA Form 21-526 for increased evaluation of heart disease, diabetes, prostate cancer residuals, and varicose veins on May 1, 2020.
- Whole decision: Remanded (sent back)November 2022
The Veteran's appeal is remanded due to a duty to assist error in obtaining an inadequate examination report prior to the December 30, 2021 rating decision. The examiner did not consider the Veteran's renal dysfunction and his testimony about changing absorbent materials at least 5 times per day.
- Whole decision: Partly grantedNovember 2022
The Veteran's appeal for TDIU was denied. The appeals for service connection for colon polyps and prostate cancer were both denied.,The appeals for service connection for right knee disorder and glaucoma are pending and will be remanded.
- Whole decision: Remanded (sent back)November 2022
The Veteran's service connection claims for systemic lupus erythematosus, COPD, ischemic heart disease, and prostate cancer are being remanded due to the submission of new evidence. The Board will consider the evidence submitted by the Veteran regarding exposure to toxins at Fort Wainwright, Alaska.
- Whole decision: GrantedNovember 2022
The Board granted service connection for metastatic prostate cancer with voiding dysfunction effective February 24, 2011, based on new evidence showing the Veteran's exposure to herbicide agents in Korea.
- Whole decision: Remanded (sent back)November 2022
The Board has found the VA's decision to deny PCAFC benefits was inadequate and remanded for an updated medical review. The case is now back with the AOJ for further action.
- Whole decision: GrantedNovember 2022
The Veteran's service-connected prostate cancer is now rated at 60 percent effective July 27, 2020. Prior to this date, the condition was rated as non-compensable.
- Whole decision: DismissedPACT Act · November 2022
The appeal for prostate cancer is dismissed as the benefits have already been granted.,Service connection for hypertension has been granted based on the PACT Act.
- Whole decision: GrantedPACT Act · November 2022
The Veteran's service connection claims for diabetes mellitus type II and prostate cancer are granted due to presumed exposure to herbicide agents during his service in Thailand, as provided by the PACT Act.
- Whole decision: DeniedNovember 2022
The Board has determined that the Veteran does not have a current diagnosis of any claimed conditions and finds no evidence to support service connection for these disabilities.
- Whole decision: GrantedNovember 2022
The Veteran's prostate cancer residuals are granted a 60 percent rating since March 3, 2015. The claim for service connection for hearing loss and tinnitus was previously granted.
- Whole decision: DeniedNovember 2022
The Veteran's prostate cancer residuals are rated at 40 percent since June 22, 2015. The Veteran is denied a higher rating for his prostate cancer and TDIU prior to July 21, 2011.
- Whole decision: GrantedPACT Act · November 2022
Service connection for prostate cancer is granted due to presumed exposure to herbicides in Thailand. Service connection for colon polyps and macular degeneration of the left eye are remanded.
- Whole decision: GrantedNovember 2022
The Veteran's prostate cancer, presumed due to herbicide exposure in Thailand, is granted service connection.,Erectile dysfunction and urinary dysfunction are secondary to the newly granted prostate cancer.
- Whole decision: Remanded (sent back)November 2022
The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's service-connected prostate cancer and related symptoms were the cause of his fatal motor vehicle accident.
- Whole decision: GrantedNovember 2022
The Veteran's prostate cancer is granted service connection as it is presumed to be due to his in-service exposure to herbicide agents, specifically Agent Orange used at Korat Royal Thai Air Force Base.
- Whole decision: GrantedNovember 2022
The Veteran's service-connected disabilities rendered him unable to secure and follow any form of substantially gainful employment prior to March 14, 2016. Basic eligibility for Dependents' Educational Assistance under 38 U.S.C. Chapter 35 is also established.
- Whole decision: Remanded (sent back)November 2022
The Board has determined that the issues of a separate rating for prostate cancer residuals on the basis of bowel incontinence and TDIU prior to September 26, 2014 are inextricably intertwined. These matters are REMANDED.
- Whole decision: Remanded (sent back)November 2022
The Board has granted service connection for diabetes mellitus, type 2, prostate cancer, and hypertension. The Veteran's peripheral neuropathy of the bilateral upper and lower extremities and erectile dysfunction are remanded due to a duty to assist error.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.